好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuroinvasive West Nile Virus Disease Presenting as Opsoclonus-Myoclonus-Ataxia Syndrome
Autoimmune Neurology
P1 - Poster Session 1 (9:00 AM-5:00 PM)
044
Describe a case of probable Neuroinvasive West Nile Virus (WNV) disease presenting as opsoclonus-myoclonus-ataxia syndrome (OMS).
Opsoclonus-myoclonus-ataxia syndrome is a well described condition which is thought to be often of paraneoplastic or autoimmune etiology in adults. Specific pathogenic antibodies have yet to be identified in most cases. It can also be seen in association with CNS infections, although it is unclear if the pathophysiology aligns more with an infectious or a para-infectious process.  Here we describe a clinical case where a patient presented with OMS, with CSF findings indicative of a diagnosis of Neuroinvasive West Nile Virus disease. 
Case Report.
A 65-year-old previously healthy man presented with 3 weeks of progressive generalized tremors, oscillopsia and inability to ambulate. Exam revealed opsoclonus, stimulus-induced myoclonus, and generalized ataxia. CSF showed neutrophil-predominant pleocytosis (325 WBCs with 78 neutrophils), which converted 3 days later to lymphocytic predominance (44 WBCs with 36 lymphocytes). CSF cultures, meningitis/encephalitis multiplex PCR array, brain MRI with and without contrast, body PET-CT and serum autoimmune encephalopathy panel were unrevealing. CSF WNV IgG and IgM were elevated to 2 times and 5 times the upper limit of assay respectively, concerning for Neuroinvasive WNV disease. He received 5 days of intravenous methylprednisolone and immunoglobulins with clinical improvement, and had ultimate resolution of symptoms over the next 6 months. 
WNV has been associated with a wide spectrum of movement disorders, and should be considered in the differential diagnosis, especially with CSF pattern as described above. Idiopathic and paraneoplastic opsoclonus-myoclonus-ataxia syndrome remains the most common subtype, however it is important to perform an evaluation for infectious etiologies as well to guide further management and counseling regarding outcome.
Authors/Disclosures
Aditi Sharma, MBBS (University of Utah)
PRESENTER 		Dr. Sharma has nothing to disclose.
Karina A. Gonzalez Otarula, MD (University of South Dakota - Sanford Health) Dr. Gonzalez Otarula has nothing to disclose.
Lama Abdel Wahed, MD (University of Iowa, Neurology) Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Resident Honorary Speaker with Iowa Neurological Association. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Author with MedLink. Dr. Abdel Wahed has received personal compensation in the range of $500-$4,999 for serving as a Author with AAN Continuum. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Invited grand round speaker with University of Maryland.
Adriana C. Rodriguez Leon, MD (University of Iowa Hospitals and Clinics) Dr. Rodriguez Leon has nothing to disclose.
Christine Gill, MD (University of Iowa Hospitals and Clinics, Department of Neurology) Dr. Gill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics .